Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion type Assertion NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_head.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion description "[PEG-ADA has also been an important adjunct to attempts to develop somatic cell gene therapy for ADA deficiency, although its continued use poses a problem for evaluation of the benefit of gene therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_provenance.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion evidence source_evidence_literature NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_provenance.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion SIO_000772 7749407 NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_provenance.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion wasDerivedFrom befree-2016 NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_provenance.
- NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_assertion wasGeneratedBy ECO_0000203 NP1320649.RA8OZrjv68PTrfHFTUiXnMH8-gcfQMr8SL2gAqzqnzUXU130_provenance.